What is Armata Pharmaceuticals, Inc. Common Stock's Market Cap?

Armata Pharmaceuticals, Inc. Common Stock's Market Cap is $216.4M, based on as-reported figures from SEC (XBRL) filings.

What is Armata Pharmaceuticals, Inc. Common Stock's Enterprise Value?

Armata Pharmaceuticals, Inc. Common Stock's Enterprise Value is $192.4M, based on as-reported figures from SEC (XBRL) filings.

What is Armata Pharmaceuticals, Inc. Common Stock's EV / EBITDA?

Armata Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Armata Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

Armata Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$192.2M, based on as-reported figures from SEC (XBRL) filings.

What is Armata Pharmaceuticals, Inc. Common Stock's EBITDA?

Armata Pharmaceuticals, Inc. Common Stock's EBITDA is -$38.9M, based on as-reported figures from SEC (XBRL) filings.

What is Armata Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

Armata Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -5.17, based on as-reported figures from SEC (XBRL) filings.

What is Armata Pharmaceuticals, Inc. Common Stock's Net Debt?

Armata Pharmaceuticals, Inc. Common Stock's Net Debt is -$24.0M, based on as-reported figures from SEC (XBRL) filings.

Armata Pharmaceuticals, Inc. Common Stock (ARMP) Financial Statements

Armata Pharmaceuticals, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001S5WNR0

XASE · usd

5.82▼ 0.02 (-0.34%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close5.84

Day's Range5.59 – 5.88

52-Week Range2.79 – 16.34

Volume47.3K

Avg Volume97.7K

Share Statistics

Shares Outstanding

Employees61

ExchangeXASE

Listed1994-05-27

Share count as of August 6, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Armata Pharmaceuticals, Inc. Common Stock (ARMP)

What is Armata Pharmaceuticals, Inc. Common Stock's Market Cap?: Armata Pharmaceuticals, Inc. Common Stock's Market Cap is $216.4M, based on as-reported figures from SEC (XBRL) filings.
What is Armata Pharmaceuticals, Inc. Common Stock's Enterprise Value?: Armata Pharmaceuticals, Inc. Common Stock's Enterprise Value is $192.4M, based on as-reported figures from SEC (XBRL) filings.
What is Armata Pharmaceuticals, Inc. Common Stock's EV / EBITDA?: Armata Pharmaceuticals, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Armata Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: Armata Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$192.2M, based on as-reported figures from SEC (XBRL) filings.
What is Armata Pharmaceuticals, Inc. Common Stock's EBITDA?: Armata Pharmaceuticals, Inc. Common Stock's EBITDA is -$38.9M, based on as-reported figures from SEC (XBRL) filings.
What is Armata Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: Armata Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -5.17, based on as-reported figures from SEC (XBRL) filings.
What is Armata Pharmaceuticals, Inc. Common Stock's Net Debt?: Armata Pharmaceuticals, Inc. Common Stock's Net Debt is -$24.0M, based on as-reported figures from SEC (XBRL) filings.